Akebia Therapeutics to Report Second Quarter Financial Results

Akebia Therapeutics (Nasdaq: AKBA) plans to release its financial results for Q2 2022 on August 4, 2022, after market closure.

Rhea-AI Summary

Akebia Therapeutics (Nasdaq: AKBA) plans to release its financial results for Q2 2022 on August 4, 2022, after market closure. The company will conduct a conference call at 4:30 p.m. ET on the same day to discuss these results and provide a business update. Listeners can join the call by dialing (833) 630-1955 (domestic) or (412) 317-1836 (international), or access the live webcast via the Investors section of Akebia's website. The call replay will be available from August 4 through August 10, 2022.

Argus Session date unavailable

+0.75% session move Open Argus

Details

News Market Reaction – AKBA

The recorded move for AKBA in the trading session of this news was +0.75%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Akebia to Host Conference Call to Provide Business Update

CAMBRIDGE, Mass., July 26, 2022 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced plans to release its financial results for the second quarter ended June 30, 2022 on Thursday, August 4, 2022 following the close of financial markets.

Akebia will host a conference call on Thursday, August 4 at 4:30 p.m. ET to discuss its financial results and provide a general business update. To listen to the conference call on August 4^th, please dial (833) 630-1955 (domestic) or (412) 317-1836 (international) and ask to join into the Akebia Therapeutics call. The call will also be webcast LIVE and can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

A replay of the conference call will be available two hours after the completion of the call through August 10, 2022. To access the replay, dial (877) 344-7529 (domestic) or (412) 317-0088 (international) and reference replay access code 3608580. An online archive of the conference call can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-second-quarter-financial-results-301592484.html

SOURCE Akebia Therapeutics

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Akebia release its Q2 2022 financial results?

Akebia will release its Q2 2022 financial results on August 4, 2022.

What time is the Akebia conference call about financial results?

The Akebia conference call will take place at 4:30 p.m. ET on August 4, 2022.

How can I access the Akebia conference call?

You can access the Akebia conference call by dialing (833) 630-1955 (domestic) or (412) 317-1836 (international), or through a live webcast on their website.

Will there be a replay of the Akebia conference call?

Yes, a replay of the conference call will be available from two hours after the call until August 10, 2022.